CH611910A5 - - Google Patents

Info

Publication number
CH611910A5
CH611910A5 CH1020975A CH1020975A CH611910A5 CH 611910 A5 CH611910 A5 CH 611910A5 CH 1020975 A CH1020975 A CH 1020975A CH 1020975 A CH1020975 A CH 1020975A CH 611910 A5 CH611910 A5 CH 611910A5
Authority
CH
Switzerland
Application number
CH1020975A
Inventor
Otto Dr Engelfried
Ulrich Dr Kerb
Rudolf Prof Dr Wiechert
Helmut Dr Wachtel
Dieter Dr Palenschat
Reinhard Dr Horowski
Gert Dr Paschelke
Wolfgang Dr Kehr
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of CH611910A5 publication Critical patent/CH611910A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CH1020975A 1974-08-05 1975-08-05 CH611910A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2438020A DE2438020A1 (de) 1974-08-05 1974-08-05 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung

Publications (1)

Publication Number Publication Date
CH611910A5 true CH611910A5 (xx) 1979-06-29

Family

ID=5922668

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1020975A CH611910A5 (xx) 1974-08-05 1975-08-05

Country Status (17)

Country Link
US (1) US4029777A (xx)
JP (1) JPS5141347A (xx)
AT (1) AT345998B (xx)
BE (1) BE832124A (xx)
CA (1) CA1037027A (xx)
CH (1) CH611910A5 (xx)
CS (2) CS175500B2 (xx)
DD (1) DD120192A5 (xx)
DE (1) DE2438020A1 (xx)
DK (1) DK136369C (xx)
ES (1) ES439720A1 (xx)
FR (1) FR2281123A1 (xx)
GB (1) GB1512258A (xx)
HU (1) HU171684B (xx)
IL (1) IL47770A (xx)
NL (1) NL7509326A (xx)
SE (1) SE404804B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61144199A (ja) * 1984-12-18 1986-07-01 Pioneer Electronic Corp スピ−カ用紙製振動部材の製造方法
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
AU609927B2 (en) * 1987-08-25 1991-05-09 Kelvin W. Gee Compositions and methods for alleviating stress, anxiety and seizure activity
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
RU2700264C2 (ru) 2013-04-17 2019-09-16 Сейдж Терапьютикс, Инк. 19-нор нейроактивные стероиды и способы их применения
KR102239541B1 (ko) 2013-04-17 2021-04-14 세이지 테라퓨틱스, 인크. 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
EP3868382A1 (en) 2013-07-19 2021-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
LT3488852T (lt) 2013-08-23 2021-02-25 Sage Therapeutics, Inc. Neuroaktyvūs steroidai, kompozicijos, ir jų naudojimas
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
BR112017007902B1 (pt) 2014-10-16 2023-12-05 Sage Therapeutics, Inc Composto e seu sal, composição farmacêutica e uso do referido composto e seu sal na fabricação de um medicamento para o tratamento de distúrbios do sistema nervoso central
LT3206493T (lt) 2014-10-16 2020-08-25 Sage Therapeutics, Inc. Kompozicijos ir būdai, skirti cns sutrikimams gydyti
SI3224269T1 (sl) 2014-11-27 2020-10-30 Sage Therapeutics, Inc. Sestavki in metode za zdravljenje CNS motenj
ES2857082T3 (es) 2015-01-26 2021-09-28 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos del SNC
JP6875996B2 (ja) 2015-02-20 2021-05-26 セージ セラピューティクス, インコーポレイテッド 神経刺激性ステロイド、組成物、およびその使用
DK3481844T3 (da) 2016-07-11 2024-07-22 Sage Therapeutics Inc C7, C12 og C16 substituerede neuroaktive steroider og disses fremgangsmåder til anvendelse
MA45599A (fr) 2016-07-11 2019-05-15 Sage Therapeutics Inc Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
BR112020012712A8 (pt) * 2017-12-22 2022-03-03 Sage Therapeutics Inc Composto ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica e usos do referido composto para o tratamento de distúrbios do snc
WO2020243488A1 (en) 2019-05-31 2020-12-03 Sage Therapeutics, Inc. Neuroactive steroids and compositions thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1409239A (en) * 1971-11-11 1975-10-08 Glaxo Lab Ltd Process for the preparation of 3alpha-hydroxy-5alpha-steroids
BE791196A (fr) * 1971-11-11 1973-05-10 Glaxo Lab Ltd Nouveaux steroides, leur procede de preparation et leurs applications

Also Published As

Publication number Publication date
DK136369B (da) 1977-10-03
DK344475A (da) 1976-02-06
JPS5141347A (en) 1976-04-07
SE7508777L (sv) 1976-02-06
SE404804B (sv) 1978-10-30
ATA600475A (de) 1978-02-15
CA1037027A (en) 1978-08-22
DE2438020A1 (de) 1976-02-26
GB1512258A (en) 1978-05-24
US4029777A (en) 1977-06-14
HU171684B (hu) 1978-02-28
AU8351575A (en) 1977-02-03
ES439720A1 (es) 1977-03-01
NL7509326A (nl) 1976-02-09
CS175500B2 (xx) 1977-05-31
DK136369C (da) 1978-02-27
DD120192A5 (xx) 1976-06-05
AT345998B (de) 1978-10-10
FR2281123A1 (fr) 1976-03-05
IL47770A0 (en) 1975-10-15
IL47770A (en) 1978-10-31
BE832124A (fr) 1976-02-05
CS175498B2 (xx) 1977-05-31

Similar Documents

Publication Publication Date Title
FR2257700B1 (xx)
CS175500B2 (xx)
FR2261813B3 (xx)
FR2267839B1 (xx)
FR2259058B1 (xx)
FR2277090B1 (xx)
JPS50103489A (xx)
FR2288022B1 (xx)
FR2267315A1 (xx)
FR2284981B1 (xx)
FR2275266B1 (xx)
FR2293828B1 (xx)
FR2272998B1 (xx)
DK72475A (xx)
FR2284269B3 (xx)
FR2276010B3 (xx)
FR2274051B1 (xx)
FI196874A (xx)
AU7099174A (xx)
AU7138274A (xx)
CS169348B1 (xx)
CH599604B5 (xx)
CH1357474A4 (xx)
AU481580A (xx)
BG22203A1 (xx)

Legal Events

Date Code Title Description
PL Patent ceased